Bio-Rad Laboratories | BIO - Betriebsaufwand

Aktienkurs
287.84
Täglich Wechseln
6.42 2.28%
Monatlich
5.20%
Jährlich
18.77%
Q2 Prognose
281.68




Betriebsaufwand Veränderung Datum
Abbott USD 9.31B 104M 2026-03
Agilent USD 1.44B 27M 2025-12
Becton, Dickinson and Co. USD 4.59B 476M 2025-12
Bio Techne USD 241.42M 2.52M 2025-12
Bio-Rad Laboratories USD 6.74B 6.16B 2025-09
Bruker USD 900.9M 124.3M 2025-12
Charles River Laboratories USD 918.41M 2.49B 2025-12
Danaher USD 52.95B 47.61B 2026-03
General Electric Aerospace USD 18.06B 7.11B 2026-03
Illumina USD 903M 69M 2025-12
IQVIA Holdings USD 1.69B 4.47B 2025-12
Laboratory Of America USD 3.13B 32.4M 2025-12
Merck USD 10.16B 558M 2025-12
Mettler Toledo International USD 777.8M 42.3M 2025-12
Myriad Genetics USD 212.8M 16.2M 2025-12
OraSure Technologies USD 40.35M 2.45M 2025-12
Pacific Biosciences Of California USD 97.83M 41.29M 2025-12
Quest Diagnostics USD 2.5B 76M 2026-03
Repligen USD 177.94M 1.82M 2025-12
Revvity USD 626.22M 25.62M 2025-12
Roche Holding CHF 21.01B 10.84B 2025-12
Siemens EUR 16.57B 2.29B 2025-12
Standard Biotools USD 45.72M 2.7M 2025-12
Thermo Fisher Scientific USD 9.09B 821M 2026-03
Tosoh JPY 231.79B 6.44B 2025-12
Waters USD 661.85M 1.67B 2025-12